Potential of B24O24 nanocluster for sensing and delivering chlormethine anticancer drug: a DFT study
- PMID: 35900596
- DOI: 10.1007/s00894-022-05224-6
Potential of B24O24 nanocluster for sensing and delivering chlormethine anticancer drug: a DFT study
Abstract
In the present research, the adsorption and release of chlormethine (CM) drug on the B24O24 nanocage have been reported in the water media and gas phase at GGA/PBE/DNP computational level. The interaction between B24O24 nanocage and CM drug shows that adsorptions of the chlormethine on B24O24 nanocage for the most stable complexes are - 1.47 to - 1.36 eV in the gas phase and water media, respectively. The CM adsorption caused a notable change in the band gap (Eg) and work function (Φ) of the B24O24 nanocage in the studied complexes. The binding of chlormethine to B24O24 also significantly increased the polarity of the drug carrier, which is a desirable property for drug delivery in biological environments. CM drugs can be released from the nanocage in the presence of an external electric field along the X-axis direction. The present study results show that the B24O24 nanocage is a possible carrier for delivering chlormethine drugs.
Keywords: Adsorption; B24O24 nanocage; Chlormethine; DFT; Drug.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Comparative study of the therapeutic potential of C24, C32, B12N12, and B16N16 nanocages as drug delivery carriers for delivering an erlotinib derivative: DFT and QTAIM investigations.Nanoscale. 2025 May 9;17(18):11413-11425. doi: 10.1039/d4nr05393a. Nanoscale. 2025. PMID: 40242881
-
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.Am J Clin Dermatol. 2021 May;22(3):407-414. doi: 10.1007/s40257-021-00591-x. Epub 2021 Mar 3. Am J Clin Dermatol. 2021. PMID: 33656660 Free PMC article.
-
Capacities of metal-doped nanocages for flutamide and cyclophosphamide delivery as anticancer drug.J Mol Model. 2024 Dec 5;31(1):11. doi: 10.1007/s00894-024-06231-5. J Mol Model. 2024. PMID: 39636372
-
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region).J Dtsch Dermatol Ges. 2022 May;20(5):579-586. doi: 10.1111/ddg.14688. Epub 2022 Apr 15. J Dtsch Dermatol Ges. 2022. PMID: 35429108 Review.
-
Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.Dermatol Ther (Heidelb). 2021 Aug;11(4):1085-1106. doi: 10.1007/s13555-021-00539-3. Epub 2021 May 21. Dermatol Ther (Heidelb). 2021. PMID: 34021485 Free PMC article. Review.
Cited by
-
Metal-Metalloid Modified C36 Fullerene: A Dual Role in Drug Delivery and Sensing for Anticancer Chlormethine Explored through DFT and MD Simulations.ACS Omega. 2024 Dec 2;9(50):49786-49803. doi: 10.1021/acsomega.4c08490. eCollection 2024 Dec 17. ACS Omega. 2024. PMID: 39713662 Free PMC article.
References
-
- Prelog V, Štěpán V (1935) Nouvele synthèse des pipérazines N-monoalcoylées (VII ième communication sur les bis-[β-halogénoéthyl]-amines). Collect Czech Chem Commun 7:93–102 - DOI
-
- Hultgren TL, Jones D, Duvic M (2007) Topical nitrogen mustard for the treatment of granulomatous slack skin. Am J Clin Dermatol 8(1):51–54 - DOI
-
- Vonderheid EC, Tan ET, Kantor AF, Shrager L, Micaily B, Van Scott EJ (1989) Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 20(3):416–428. https://doi.org/10.1016/S0190-9622(89)70051-7 - DOI - PubMed
-
- Lipp H-P, Hartmann J (2009) Cytostatic and cytotoxic drugs. Side Eff Drugs Annu Elsevier 31:721–729. https://doi.org/10.1016/S0378-6080(09)03145-6
-
- Lessin SR, Duvic M, Guitart J, Pandya AG, Strober BE, Olsen EA, Hull CM, Knobler EH, Rook AH, Kim EJ (2013) Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides. JAMA Dermatol 149(1):25–32
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous